FundedIQ
Biotechnology

Magdent: Funding, Investors & Team (Oct 2026)

Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and improve bone formation and enable shorter and more successful healing of bone and soft tissue in events such as a fracture or dental implant. Magdent’s solutions are high usability medical devices that incorporate a battery, electronic modules, and a coil. The orthopedic device is a thin lightweight silicon patch, placed over the fracture either under the case or over the skin while the dental device is shaped like a healing abutment.

www.magdentmed.com LinkedIn Ramat Gan, Israel 11-50 employees
Biotechnology Dental Life Science Manufacturing Medical Medical Device
Total raised
$150k
Rounds
1
Latest
Seed
Jun 2026

Magdent has raised $150k across 1 funding round on record, the most recent a Seed of $150k announced in Jun 2026.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Magdent Company Profile and Key Stats

Total funding raised
$150k
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$150k in Jun 2026
Employees
11-50
reported band
Headquarters
Ramat Gan, Israel

Latest funding round on record: Jun 2026.

Magdent Funding Rounds

Date
Round
Amount
Seed
$150k

Magdent Founders and Leadership Team

Name
Role
Contact
Nate Stobbe
Founder
—

No contact details are on record for this team yet.

Magdent Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
1,019
$14M
17,054
$3.1M

Magdent's latest round of $150k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Magdent in Biotechnology and Ramat Gan

Companies Similar to Magdent

CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…

Undisclosed round $2.6M

Brevel has created an innovative method of cultivating microalgae that is both sustainable and…

Undisclosed round $1.0M

Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…

Undisclosed round $6.5M

RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…

Undisclosed round $6.0M

IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…

Undisclosed round $5.5M

Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…

Undisclosed round $13.0M

Phytolon is transforming the process of creating food colors by using an innovative and environmentally…

Series B $23.6M

BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…

Undisclosed round $47.8M

SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…

Series A $6.0M

ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…

Undisclosed round $14.0M

MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…

Seed $3.6M

NeuroSense Therapeutics Ltd., is a clinical-stage biotechnology company, dedicated to the discovery and…

Undisclosed round $600k

Magdent Funding FAQs

What does Magdent do?

Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and improve bone formation and enable shorter and more successful healing of bone and soft tissue in events such as a fracture or dental implant. Magdent’s solutions are high usability medical devices that incorporate a battery, electronic modules, and a coil. The orthopedic device is a thin lightweight silicon patch, placed over the fracture either under the case or over the skin while the dental device is shaped like a healing abutment.

How much funding has Magdent raised?

Magdent has raised $150k across 1 round on record. The most recent is a Seed of $150k announced in Jun 2026.

When did Magdent last raise funding?

Magdent's most recent funding round on record is a Seed of $150k, announced in Jun 2026.

Who founded Magdent?

FundedIQ lists Nate Stobbe (Founder) at Magdent.

Where is Magdent headquartered?

Magdent is based in Ramat Gan, Tel Aviv, Israel.

How many employees does Magdent have?

Magdent is in the 11-50 employee band.

How does Magdent's funding compare to other Biotechnology startups?

Magdent's latest round of $150k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Magdent Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Magdent is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.